$ICUI
ICU Medical Inc Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000088398417000057 Filed on November 09, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q4
Revenue	$370.1M	$343.2M	$95.69M
YoY Change	286.8%	253.46%	5.86%
Cost Of Revenue	$232.6M	$231.6M	$44.90M
YoY Change	418.04%	405.37%	6.65%
Gross Profit	$137.5M	$111.6M	$50.76M
YoY Change	170.86%	117.65%	5.19%
Gross Profit Margin	37.15%	32.51%	53.05%
Selling, General & Admin	$75.40M	$76.82M	$22.60M
YoY Change	233.63%	243.53%	0.44%
% of Gross Profit	54.84%	68.84%	44.52%
Research & Development	$13.90M	$12.77M	$2.700M
YoY Change	414.81%	249.84%	-34.15%
% of Gross Profit	10.11%	11.44%	5.32%
Depreciation & Amortization	$19.10M	$14.00M	$4.700M
YoY Change	306.38%	250.0%	-2.08%
% of Gross Profit	13.89%	12.55%	9.26%
Operating Expenses	$84.30M	$115.3M	$25.30M
YoY Change	233.2%	300.1%	-4.89%
Operating Profit	$53.19M	-$3.702M	$25.46M
YoY Change	108.92%	-116.49%	17.56%
Interest Expense	-$300.0K	$705.0K
YoY Change		1115.52%
% of Operating Profit	-0.56%
Other Income/Expense, Net	-$2.200M	$583.0K	$300.0K
YoY Change	-833.33%	106.01%	200.0%
Pretax Income	$39.90M	$4.710M	$14.10M
YoY Change	182.98%	-79.54%	11.9%
Income Tax	-$12.90M	$4.574M	$4.600M
% Of Pretax Income	-32.33%	97.11%	32.62%
Net Earnings	$49.71M	$136.0K	$9.512M
YoY Change	422.55%	-99.28%	74.12%
Net Earnings / Revenue	13.43%	0.04%	9.94%
Basic Earnings Per Share	$2.47	$0.01	$0.58
Diluted Earnings Per Share	$2.33	$0.01	$0.54
COMMON SHARES
Basic Shares Outstanding	20.13M shares	19.98M shares	16.33M shares
Diluted Shares Outstanding		21.11M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$300.1M	$310.2M	$445.1M
YoY Change	-32.57%	-16.7%	17.94%
Cash & Equivalents	$290.1M	$300.6M	$445.1M
Short-Term Investments	$10.06M	$9.591M	$0.00
Other Short-Term Assets	$1.834M	$1.218M	$1.740M
YoY Change	5.4%	-88.72%	-85.13%
Inventory	$288.7M	$295.5M	$49.26M
Prepaid Expenses
Receivables	$112.7M	$105.1M	$56.16M
Other Receivables	$109.4M	$12.10M	$11.20M
Total Short-Term Assets	$864.7M	$906.7M	$569.1M
YoY Change	51.94%	80.24%	12.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$398.7M	$390.5M	$85.70M
YoY Change	365.23%	384.6%	15.31%
Goodwill	$12.36M	$6.687M	$5.577M
YoY Change	121.57%	19.9%	-13.71%
Intangibles	$143.8M	$152.3M	$22.38M
YoY Change	542.24%	567.21%	-6.49%
Long-Term Investments	$14.60M	$15.10M
YoY Change		-73.6%
Other Assets	$38.14M	$35.19M	$0.00
YoY Change		80.47%	-100.0%
Total Long-Term Assets	$632.3M	$616.3M	$135.6M
YoY Change	366.32%	231.95%	11.31%
TOTAL ASSETS
Total Short-Term Assets	$864.7M	$906.7M	$569.1M
Total Long-Term Assets	$632.3M	$616.3M	$135.6M
Total Assets	$1.497B	$1.523B	$704.7M
YoY Change	112.43%	121.14%	12.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$78.23M	$44.69M	$14.64M
YoY Change	434.31%	255.91%	7.1%
Accrued Expenses	$132.1M	$146.1M	$25.90M
YoY Change	409.98%	632.16%	-10.54%
Deferred Revenue	$3.326M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change
Total Short-Term Liabilities	$210.3M	$195.1M	$40.54M
YoY Change	418.77%	500.0%	-4.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$75.00M	$0.00
YoY Change
Other Long-Term Liabilities	$86.90M	$101.6M	$2.600M
YoY Change	3242.31%	3662.96%	-13.33%
Total Long-Term Liabilities	$86.90M	$75.00M	$0.00
YoY Change		2677.78%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$210.3M	$195.1M	$40.54M
Total Long-Term Liabilities	$86.90M	$75.00M	$0.00
Total Liabilities	$298.7M	$270.1M	$40.54M
YoY Change	636.86%	571.88%	-13.75%
SHAREHOLDERS EQUITY
Retained Earnings	$585.6M	$535.9M	$517.0M
YoY Change	13.28%	5.61%	13.9%
Common Stock	$627.6M	$609.7M	$164.5M
YoY Change	281.6%	282.89%	12.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$2.000K	$14.00K
YoY Change	-100.0%
Treasury Stock Shares	0.000 shares	9.000 shares	93.00 shares
Shareholders Equity	$1.198B	$1.142B	$660.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.497B	$1.523B	$704.7M
YoY Change	112.43%	121.14%	12.42%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q4
OPERATING ACTIVITIES
Net Income	$49.71M	$136.0K	$9.512M
YoY Change	422.55%	-99.28%	74.12%
Depreciation, Depletion And Amortization	$19.10M	$14.00M	$4.700M
YoY Change	306.38%	250.0%	-2.08%
Cash From Operating Activities	$84.50M	$98.80M	$21.20M
YoY Change	298.58%	267.29%	236.51%
INVESTING ACTIVITIES
Capital Expenditures	-$24.30M	-$26.20M	-$8.700M
YoY Change	179.31%	315.87%	61.11%
Acquisitions
YoY Change
Other Investing Activities	-$5.400M	-$24.70M	$109.5M
YoY Change	-104.93%	-69.05%	-453.23%
Cash From Investing Activities	-$29.60M	-$51.00M	$100.9M
YoY Change	-129.34%	-40.7%	-377.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-63.00M	10.20M	1.500M
YoY Change	-4300.0%	14.61%	-88.81%
NET CHANGE
Cash From Operating Activities	84.50M	98.80M	21.20M
Cash From Investing Activities	-29.60M	-51.00M	100.9M
Cash From Financing Activities	-63.00M	10.20M	1.500M
Net Change In Cash	-8.100M	58.00M	123.6M
YoY Change	-106.55%	-215.54%	-840.12%
FREE CASH FLOW
Cash From Operating Activities	$84.50M	$98.80M	$21.20M
Capital Expenditures	-$24.30M	-$26.20M	-$8.700M
Free Cash Flow	$108.8M	$125.0M	$29.90M
YoY Change	263.88%	276.51%	155.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	icui	Net Cash Paid Receivedforcurrentandprioracquisitions NetCashPaidReceivedforcurrentandprioracquisitions	2584000	USD
CY2017Q3	icui	Earnout Target EarnoutTarget	1000000000	USD
CY2017Q1	icui	Fair Value Assumptions Costof Debt FairValueAssumptionsCostofDebt	0.0416
	icui	Fair Value Assumptions Costof Debt FairValueAssumptionsCostofDebt	0.0394
CY2017Q1	icui	Fair Value Assumptions Expected Volatility Rate Adjusted Ebitda FairValueAssumptionsExpectedVolatilityRateAdjustedEBITDA	0.2900
	icui	Fair Value Assumptions Expected Volatility Rate Adjusted Ebitda FairValueAssumptionsExpectedVolatilityRateAdjustedEBITDA	0.2800
CY2017Q1	icui	Fair Value Assumptions Market Priceof Risk FairValueAssumptionsMarketPriceofRisk	0.0693
	icui	Fair Value Assumptions Market Priceof Risk FairValueAssumptionsMarketPriceofRisk	0.0618
	icui	Fee Cap First Twelve Months FeeCapFirstTwelveMonths	62500000	USD
	icui	Fee Cap Sixmonthssubsequenttofirsttwelvemonths FeeCapSixmonthssubsequenttofirsttwelvemonths	31300000	USD
	icui	Increase Decreasein Assumed Liabilities IncreaseDecreaseinAssumedLiabilities	-734000	USD
	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	2691000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20130535	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
CY2016Q4	icui	Accrued Product Field Action. AccruedProductFieldAction.	0	USD
CY2017Q3	icui	Accrued Product Field Action. AccruedProductFieldAction.	15225000	USD
CY2016Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	5702000	USD
CY2017Q3	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	50964000	USD
CY2016Q4	icui	Accruedlegalfees Accruedlegalfees	4177000	USD
CY2017Q3	icui	Accruedlegalfees Accruedlegalfees	2567000	USD
	icui	Bargainpurchasegainnoncashaddback Bargainpurchasegainnoncashaddback	1456000	USD
	icui	Bargainpurchasegainnoncashaddback Bargainpurchasegainnoncashaddback	71771000	USD
CY2017Q3	icui	Business Combination Consideration Transferred Equity Issued Fair Value BusinessCombinationConsiderationTransferredEquityIssuedFairValue	-413139000	USD
	icui	Business Combination Consideration Transferred Equity Issued Fair Value BusinessCombinationConsiderationTransferredEquityIssuedFairValue	413139000	USD
	icui	Contingentconsiderationgross Contingentconsiderationgross	225000000	USD
CY2017Q3	icui	Discountonequityissuedasconsideration Discountonequityissuedasconsideration	37261000	USD
	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-13982000	USD
CY2016Q4	icui	Liabilitiesforcontracts Liabilitiesforcontracts	0	USD
CY2017Q3	icui	Liabilitiesforcontracts Liabilitiesforcontracts	54642000	USD
CY2016Q4	icui	Miscellaneousacquisitionrelatedaccrual Miscellaneousacquisitionrelatedaccrual	2750000	USD
CY2017Q3	icui	Miscellaneousacquisitionrelatedaccrual Miscellaneousacquisitionrelatedaccrual	0	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2228000	USD
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	987000	shares
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	584000	USD
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred	0	USD
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred	7512000	USD
	icui	Net Cash Paid Receivedforcurrentandprioracquisitions NetCashPaidReceivedforcurrentandprioracquisitions	157097000	USD
CY2016Q4	icui	Outsidesalescommissions Outsidesalescommissions	1141000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	394000	USD
CY2017Q3	icui	Outsidesalescommissions Outsidesalescommissions	2822000	USD
CY2017Q3	icui	Paymenttoacquirebusinessnetofworkingcapitaladjustments Paymenttoacquirebusinessnetofworkingcapitaladjustments	177527000	USD
CY2016Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	1649000	USD
CY2017Q3	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	1401000	USD
CY2016Q4	icui	Prepaidothertaxes Prepaidothertaxes	1018000	USD
CY2017Q3	icui	Prepaidothertaxes Prepaidothertaxes	3602000	USD
CY2016Q4	icui	Prepaids Hi Stransaction PrepaidsHIStransaction	0	USD
CY2017Q3	icui	Prepaids Hi Stransaction PrepaidsHIStransaction	46241000	USD
	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	-22000	USD
	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	3639000	USD
CY2016Q3	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	2806000	USD
	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	4339000	USD
CY2017Q3	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	18711000	USD
	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	68033000	USD
CY2016Q3	icui	Strategic Transaction Costs StrategicTransactionCosts	1100000	USD
CY2016Q3	icui	Strategictransactionexpenses Strategictransactionexpenses	2400000	USD
	icui	Strategictransactionexpenses Strategictransactionexpenses	3500000	USD
CY2017Q3	icui	Strategictransactionexpenses Strategictransactionexpenses	15500000	USD
	icui	Strategictransactionexpenses Strategictransactionexpenses	49000000	USD
CY2016	icui	Thirdparty Inventory ThirdpartyInventory	0	USD
	icui	Thirdparty Inventory ThirdpartyInventory	3008000	USD
	icui	Transitional Service Agreement Setup Costs TransitionalServiceAgreementSetupCosts	22000000	USD
CY2017Q3	icui	Treasury Stock Purchase Plan TreasuryStockPurchasePlan	40000000	USD
CY2017Q3	invest	Derivative Notional Amount DerivativeNotionalAmount	600300000	MXN
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14641000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	44685000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	56161000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	105090000	USD
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	7912000	USD
CY2017Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	26014000	USD
CY2016Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	1107000	USD
CY2017Q3	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	3738000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2017Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4263000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1519000	USD
CY2017Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1519000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25896000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	146147000	USD
CY2016Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	0	USD
CY2017Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2125000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	0	USD
CY2017Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	8945000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	158259000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	197515000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21272000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3778000	USD
CY2017Q3	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P9Y0M
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	162828000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	607694000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1073000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3256000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10900000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	48	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	590	shares
CY2016Q4	us-gaap	Assets Assets	704688000	USD
CY2017Q3	us-gaap	Assets Assets	1522974000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	569097000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	906701000	USD
CY2017Q3	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	26319000	USD
CY2017Q3	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	12489000	USD
CY2016Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2017Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	12489000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	24731000	USD
	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	102000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	0	USD
CY2017Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	9591000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15054000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	9575000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	24629000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9591000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	15140000	USD
CY2016Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	0	USD
	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	3200000	shares
CY2017Q3	us-gaap	Business Acquisition Share Price BusinessAcquisitionSharePrice	140.75
CY2017Q3	us-gaap	Business Combination Acquired Receivables Fair Value BusinessCombinationAcquiredReceivablesFairValue	362000	USD
CY2016Q3	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	346000	USD
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	1456000	USD
CY2017Q3	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	8534000	USD
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	71771000	USD
CY2017Q3	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	684666000	USD
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
CY2017Q3	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	450400000	USD
CY2016Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	13000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	19000000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	29475000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	17255000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	12381000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	54794000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent	30417000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	5000000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	131000000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	417470000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	786854000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	31283000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	68510000	USD
CY2017Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	295694000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	595000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1435000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	336164000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	322963000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	445082000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300614000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-13201000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-144468000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	445082000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	310205000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16338000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20021000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16338000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20021000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1633000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	2002000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19506000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56104000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5745000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36433000	USD
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	15180000	USD
CY2017Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	49788000	USD
	us-gaap	Interest Expense InterestExpense	135000	USD
CY2017Q3	us-gaap	Contractual Obligation ContractualObligation	214208000	USD
CY2017Q3	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	9551000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	42437000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	113434000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	16883000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	22989000	USD
CY2017Q3	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	8914000	USD
CY2016Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2017Q3	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	45835000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	133046000	USD
CY2017Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	231638000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	633884000	USD
	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	Interest on the Senior Note is variable and will accrue at LIBOR plus (i) 2.25% per year for the first 12 months, and (ii) 2.50% per annum thereafter.
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2020-02-03
	us-gaap	Debt Instrument Restrictive Covenants DebtInstrumentRestrictiveCovenants	The Senior Note has restrictions, beginning on the effective date and thereafter, pertaining to limitations on debt, liens, loans, advances, acquisitions, other investments, dividends, redemptions, repurchases of equity interests, fundamental changes in the line of business, dispositions, transactions with affiliates, dividend and payment restrictions affecting subsidiaries, changes in line of business and accounting changes or change in fiscal year.
CY2017Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	75000000	USD
CY2016Q4	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	18000	USD
CY2017Q3	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	5937000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	USD
CY2017Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5787000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	21935000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	16390000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1370000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	9491000	USD
CY2016Q3	us-gaap	Depreciation Depreciation	4000000	USD
	us-gaap	Depreciation Depreciation	12300000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	14000000	USD
	us-gaap	Depreciation Depreciation	36600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14351000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	47512000	USD
CY2017Q3	us-gaap	Derivative Forward Exchange Rate1 DerivativeForwardExchangeRate1	20.01
CY2016Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2017Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	534000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	556000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.32
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.97
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.13
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1664000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	4194000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.66
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	6600000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	12600000	USD
CY2017Q1	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0282
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0263
CY2017Q1	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.1000
	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.0900
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	13000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	19000000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	32000000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	4081000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	893582000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24542000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27494000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	77108000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4218000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	15716000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15798000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15938000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	16353000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	46925000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	172625000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22383000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	145131000	USD
CY2017Q3	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	1300000	USD
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3243000	USD
CY2017Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	4174000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-40000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3177000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	5577000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	6687000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1015000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	95000	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	-775000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	51273000	USD
	us-gaap	Gross Profit GrossProfit	150638000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	111598000	USD
	us-gaap	Gross Profit GrossProfit	288605000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23026000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	71075000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4710000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11381000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4220000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17503000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4574000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7558000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1587000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	17551000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4736000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	51498000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7314000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	63234000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6635000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-148482000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	125403000	USD
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1086000	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1122000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1170000	shares
CY2017Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7207000	USD
CY2017Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	179832000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22383000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	152338000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	58000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	705000	USD
	us-gaap	Interest Expense InterestExpense	1743000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16414000	USD
CY2017Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	182015000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	49264000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	320341000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	28435000	USD
CY2017Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	74356000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4415000	USD
CY2017Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	63970000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	1026000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	12000	USD
CY2016Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5300000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	704688000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1522974000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	166102000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	40537000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	195095000	USD
CY2016Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	1107000	USD
CY2017Q3	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	68034000	USD
CY2017Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	75000000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2017Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75000000	USD
CY2016Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	96536000	USD
CY2017Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	242619000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1036000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18721000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84608000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-237258000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	68707000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	69875000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	283000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-56000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	583000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2030000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	28818000	USD
	us-gaap	Operating Expenses OperatingExpenses	81468000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	115300000	USD
	us-gaap	Operating Expenses OperatingExpenses	345222000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	22455000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	69170000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3702000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-56617000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	33763000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2638000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3219000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	3378000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5769000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	9208000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9551000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2301000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20007000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	0	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	765000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1740000	USD
CY2017Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1218000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35192000	USD
CY2017Q3	us-gaap	Other Commitment OtherCommitment	7475000	USD
CY2017Q3	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	0	USD
CY2017Q3	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	0	USD
CY2017Q3	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	299000	USD
CY2017Q3	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	3198000	USD
CY2017Q3	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	3215000	USD
CY2017Q3	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	763000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	238000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	17838000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-134000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	985000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	0	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	-82000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	603000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	700000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2532000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	5833000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	700000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2532000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16747000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	19000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5609000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	17494000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	90000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	69000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	1690000	USD
CY2016Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2948000	USD
CY2017Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	8633000	USD
CY2016Q4	us-gaap	Other Receivables OtherReceivables	0	USD
CY2017Q3	us-gaap	Other Receivables OtherReceivables	85376000	USD
CY2016Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	10000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	25000	USD
CY2017Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	152000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	945000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	17155000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3951000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	14741000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4000000	USD
CY2017Q3	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	260000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2584000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	157097000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	861000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3718000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	111575000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	24743000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15018000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	51702000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7355000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	146471000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	11235000	USD
CY2017Q3	us-gaap	Prepaid Taxes PrepaidTaxes	12105000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2017Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	75000000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2361000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2705000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	45429000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15830000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19967000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0	USD
CY2017Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1335000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	0	USD
CY2017Q3	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3102000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	18806000	USD
	us-gaap	Profit Loss ProfitLoss	53572000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	136000	USD
	us-gaap	Profit Loss ProfitLoss	18939000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	243955000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	588041000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	85696000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	390526000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1906000	USD
CY2017Q3	us-gaap	Purchase Obligation PurchaseObligation	97970000	USD
CY2017Q3	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	USD
CY2017Q3	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	39218000	USD
CY2017Q3	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	34757000	USD
CY2017Q3	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	5513000	USD
CY2017Q3	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	4477000	USD
CY2017Q3	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	14005000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-344000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3650000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10301000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12769000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37377000	USD
	us-gaap	Restructuring Charges RestructuringCharges	19010000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	1530000	USD
CY2017Q3	us-gaap	Restructuring Reserve RestructuringReserve	3830000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-1969000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	423000	USD
CY2017Q3	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3002000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	516980000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	535919000	USD
CY2016Q3	us-gaap	Revenues Revenues	97108000	USD
	us-gaap	Revenues Revenues	283684000	USD
CY2017Q3	us-gaap	Revenues Revenues	343236000	USD
	us-gaap	Revenues Revenues	922489000	USD
CY2016Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	1472000	USD
CY2017Q3	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	339000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	97098000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	283659000	USD
CY2017Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	343084000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	921544000	USD
CY2016Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	0	USD
CY2017Q3	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	3857000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22362000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	66828000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	76820000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	226812000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11464000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13387000	USD
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	27129	shares
CY2017Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	7200000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	660155000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1141835000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	93	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	9	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	14000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17286000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17100000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21106000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20603000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16200000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16113000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19984000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19433000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In August, 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. The amendments in this update change both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results to facilitate financial reporting that more closely reflects an entity's risk management activities. The amendments in this update also make certain targeted improvements to simplify the application of hedge accounting guidance and ease the administrative burden of hedge documentation requirements and assessing hedge effectiveness. The amendments are effective for the fiscal years, and interim reporting periods within those years, beginning on or after December 15, 2018. For cash flow and net investment hedges existing at the date of adoption, an entity should apply a cumulative-effect adjustment related to eliminating the separate measurement of ineffectiveness to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year that an entity adopts the update. This ASU is not expected to have a material impact on our consolidated financial statements or related footnote disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued ASU No. 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Under the ASU, an entity will account for the effects of a modification unless (i) the fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified, (ii) the vesting conditions of the modified award are the same vesting conditions as the original award immediately before the original award is modified, and (iii) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. The amendments in this ASU are effective prospectively for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. This ASU is not expected to have a material impact on our consolidated financial statements or related footnote disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The amendments in this update remove the second step of the impairment test. An entity will apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit's carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The new guidance does not amend the optional qualitative assessment of goodwill impairment. The amendments in ASU 2017-04 are effective for the annual or interim impairment test in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. This ASU is not expected to have a material impact on our consolidated financial statements or related footnote disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments in this update provide a screen to determine when a set (integrated set of assets and activities) is not a business.  If the screen is not met, it (1) requires that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) removes the evaluation of whether a market participant could replace the missing elements. The amendments in ASU 2017-01 are effective for annual periods and interim periods within those annual periods beginning after December 15, 2017. The amendments in this ASU should be applied prospectively on or after the effective date. This ASU is not expected to have a material impact on our consolidated financial statements or related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. Current generally accepted accounting principles prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until after the asset has been sold to an outside party. The amendments in ASU 2016-16 eliminates this prohibition, accordingly an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Amendments in this update are effective for annual reporting periods beginning after December 15, 2017. Early adoption is permitted in the first interim period of an annual reporting period. The amendments should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">provides specific guidance on eight cash flow issues where current guidance is unclear or does not include any specifics on classification. The eight specific cash flow issues are: debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with zero coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies, including bank-owned policies; distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. The amendments in ASU 2016-15 are effective for annual periods and interim periods within those annual periods beginning after December 15, 2017. Early adoption is permitted. If adopted in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes the interim period. Amendments should be applied using a retrospective transition method to each period presented. This ASU is not expected to have a material impact on our consolidated financial statements or related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This update amends the FASB's guidance on the impairment of financial instruments by requiring timelier recording of credit losses on loans and other financial instruments. The ASU adds an impairment model that is based on expected losses rather than incurred losses. The ASU also amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted as of the fiscal years beginning after December 15, 2018. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments in this update require an entity to recognize a right-of-use asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which amends certain aspects of recognition, measurement, presentation and disclosure of financial instruments. This amendment requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in the consolidation of the investee). The amendments in this update will be effective for fiscal years beginning after December 15, 2017. Early adoption of the amendments is not permitted with the exception of the provision requiring the recognition in other comprehensive income the fair value change from instrument-specific credit risk measured using the fair value option for financial instruments. This ASU is not expected to have a material impact on our consolidated financial statements or related disclosures.</font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">        </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. This guidance requires that an entity depict the consideration by applying a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. On April 1, 2015, the FASB voted for a one-year deferral of the effective date of the new revenue recognition standard, ASU 2014-09.  On July 15, 2015, the FASB affirmed these changes, which requires public entities to apply the amendments in ASU 2014-09 for annual reporting beginning after December 15, 2017. Early adoption is permitted beginning after December 31, 2016, the original effective date in ASU 2014-09. Subsequent to the issuance of this ASU, the FASB issued three amendments: ASU No. 2016-08 which clarifies principal versus agent considerations; ASU 2016-10 which clarifies guidance related to identifying performance obligations and licensing implementation; and ASU 2016-12 which provides narrow-scope improvements and practical expedients. All of the amendments have the same effective dates mentioned above. We previously disclosed that we did not anticipate a material impact on our consolidated financial statements from adoption of any of the above. In light of the Hospira Infusion Systems ("HIS") acquisition we are still evaluating the impact of this ASU on our Infusion Systems revenue. We expect to have enhanced disclosures upon adoption of this ASU. We now expect to adopt the modified restrospective method when adopting this ASU.</font></div></div>

Files In Submission

Name	View Source	Status
0000883984-17-000057-index-headers.html	Edgar Link	pending
0000883984-17-000057-index.html	Edgar Link	pending
0000883984-17-000057.txt	Edgar Link	pending
0000883984-17-000057-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icui-20170930.xml	Edgar Link	completed
icui-20170930.xsd	Edgar Link	pending
icui-20170930_cal.xml	Edgar Link	unprocessable
icui-20170930_def.xml	Edgar Link	unprocessable
icui-20170930_lab.xml	Edgar Link	unprocessable
icui-20170930_pre.xml	Edgar Link	unprocessable
icui-ex101creditagreement.htm	Edgar Link	pending
icui-ex311_20170930x10q.htm	Edgar Link	pending
icui-ex312_x20170930x10q.htm	Edgar Link	pending
icui-ex321_x20170930x10q.htm	Edgar Link	pending
icui0930201710-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU Medical Inc Stock $icui

2017 Q4 Form 10-Q Financial Statement

#000088398417000057 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU Medical Inc Stock $icui

2017 Q4 Form 10-Q Financial Statement

#000088398417000057 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU Medical Inc Stock $icui